Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
161 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 44.11 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 43.95 | Oscillator | Neutral |
| Williams %R (14) | -50.42 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.71 (Hist -0.02) | Oscillator | Strong Sell |
| Average Directional Index (14) | 33.27 (+DI 10.4 / -DI 23.6) | Trend | Strong Sell |
Current price $18.34
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 8, 26 |
| EMA 20 | 18.79 | MA | Sell |
| SMA 20 | 18.85 | MA | Sell |
| EMA 50 | 19.24 | MA | Strong Sell |
| SMA 50 | 20.26 | MA | Strong Sell |
| SMA 200 | — | MA | Neutral |
| Mizuho |
| maintain |
| Outperform |
| Outperform |
| Sep 3, 26 | Morgan Stanley | maintain | Overweight | Overweight |
| Sep 2, 26 | Evercore ISI Group | maintain | Outperform | Outperform |
| Sep 2, 26 | Wells Fargo | maintain | Overweight | Overweight |
| Sep 2, 26 | Mizuho | maintain | Outperform | Outperform |
| Sep 2, 26 | B of A Securities | maintain | Buy | Buy |
| Sep 2, 26 | UBS | maintain | Buy | Buy |
| Sep 2, 26 | Citigroup | maintain | Buy | Buy |
| Sep 1, 26 | BTIG | maintain | Buy | Buy |
TTM vs. 5-year historical average (annual ratios)
| Metric | MMED | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -15.3x | -32.9x · sector 20.7x | Discount |
| Forward P/E (FY27E) | 26.2x | EPS est. 0.70 | Discount |
| Price / Book | 1.4x | 1.0x | Elevated |
| Price / Sales | 1.6x | 1.9x | In line |
| EV / EBITDA | 29.7x | 37.9x | Discount |
| Return on equity | -9.1% | — | Weak |
| Gross margin | 53.8% | 56.7% | In line |
| Debt / Equity | 0.02 | 0.01 | Conservative |
| Piotroski / Altman Z | 3/9 | Z 3.64 | Safe zone |
Discounted cash flow model
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| SC 13G | Oct 22, 2026 | 2026-10-22 16:16:36 | View |
| 4 | Oct 19, 2026 | 2026-10-19 18:51:05 | View |
| 4 | Oct 19, 2026 | 2026-10-19 18:49:39 | View |
| 4 | Oct 19, 2026 | 2026-10-19 18:47:56 | View |
| 4 | Oct 16, 2026 | 2026-10-16 17:20:39 | View |
| 4 | Oct 16, 2026 | 2026-10-16 17:18:53 | View |
| 4 | Oct 16, 2026 | 2026-10-16 17:12:29 | View |
| 3 | Oct 16, 2026 | 2026-10-16 16:58:36 | View |
| SC 13G/A | Oct 16, 2026 | 2026-10-16 16:21:24 | View |
| 4 | Oct 16, 2026 | 2026-10-16 16:18:01 | View |
Proxy statement (DEF 14A) disclosures
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 15, 26 | Lofton Kevin E | director | A-Award | 836 | — |
| Oct 15, 26 | Dianaty Ali | officer: EVP Ch. Prod. & Tech Officer | A-Award | 11,108 | — |
| Oct 15, 26 | Chandrasena Gillian | officer: SVP, Chief HR Officer | A-Award | 1,800 | — |
| Oct 15, 26 | Hopkins Robert (Bob) | director | A-Award | 11,877 | — |
| Oct 15, 26 | Endicott David J. | director | A-Award | 3,374 | — |
| Oct 15, 26 | Bricker Amy | director | A-Award | 11,877 | — |
| Oct 15, 26 | Bricker Amy | director: | 0 | — | |
| Oct 15, 26 | Medtronic Plc | 10 percent owner | J-Other | 252,813,348 | — |
Stock news · updated daily
A recent spinoff could pave the way for greater dividend growth.
/PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the
Directors bring expertise across healthcare access, medtech, commercial and manufacturing operations and public-company governance as MiniMed begins its next chapter as an independent company focused on making every day a better day for people with diabetes. NORTHRIDGE, Calif.
GALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced the completion of its separation of MiniMed Group, Inc. (MiniMed; Nasdaq: MMED). "I'm incredibly proud of what MiniMed and Medtronic have accomplished together and the meaningful difference we've made in the lives of people with diabetes," said Geoff Martha, Medtronic Chairman and Chief Executive Officer.
NORTHRIDGE, Calif., Oct. 15, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) today announced the completion of its separation from Medtronic plc ("Medtronic"; NYSE: MDT), marking its first day as a fully independent company.
GALWAY, Ireland, Oct. 14, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced the final results of its previously announced offer to exchange shares of common stock of MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) for outstanding Medtronic ordinary shares at an exchange ratio determined by a formula described in a registration statement filed by MiniMed on Form S-4 (Reg No. 333-298914).
Short sellers are betting heavily against 10 stocks, and the fuse is getting shorter. Each one has more than 38% of its float sold short, with market caps above $2 billion and average daily volume above 1 million shares, according to Benzinga Pro screener data as of Oct. 12.
MiniMed Group Inc (NASDAQ: MMED - Get Free Report)'s share price gapped down before the market opened on Monday. The stock had previously closed at $19.71, but opened at $18.87. MiniMed Group shares last traded at $19.3280, with a volume of 3,846,634 shares. Analyst Upgrades and Downgrades Several research analysts have commented on the stock. Morgan
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Sep 1, 2026 | 0.12 | 0.12 | Miss -3.3% | $843.0M |
| Jun 3, 2026 | -0.15 | -0.68 | Miss -356.2% | $837.0M |
| Apr 17, 2026 | 0.17 | -0.16 | Miss -194.0% | $790.0M |